Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ping An Insurance | Shanghai | Financial | Insurance | CN¥941.42B | 7.9x | 0.2 | CN¥51.96 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.1% Upside | Upgrade to Pro+ | |
China Life Insurance A | Shanghai | Financial | Insurance | CN¥885.28B | 3.3x | 0.06 | CN¥37.89 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.9% Downside | Upgrade to Pro+ | |
China Pacific Insurance | Shanghai | Financial | Insurance | CN¥306.02B | 7.2x | 0.11 | CN¥31.79 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
People's Insurance | Shanghai | Financial | Insurance | CN¥299.55B | 4.3x | 0.04 | CN¥7.36 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
New China Life Insurance | Shanghai | Financial | Insurance | CN¥155.95B | 5.7x | 0.02 | CN¥50.04 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.9% Downside | Upgrade to Pro+ | |
COFCO Capital Holdings | Shenzhen | Financial | Insurance | CN¥28.02B | 41.9x | -0.71 | CN¥12.16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hubei Biocause Pharmaceutical | Shenzhen | Financial | Insurance | CN¥13.54B | -18.3x | 0.06 | CN¥2.74 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangxi Tianli Technology INC | Shenzhen | Financial | Insurance | CN¥4.23B | 178.4x | -54.35 | CN¥21.41 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |